FCY2/YER056C Literature Guide Help

Other names published for FCY2: BRA7, YER056C

FCY2 - Mutants/Phenotypes (19)

ReferenceOther Genes Addressed
Quinto-Alemany D, et al.  (2012) Yeasts acquire resistance secondary to antifungal drug treatment by adaptive mutagenesis. PLoS One 7(7):e42279
Lanthaler K, et al.  (2011) Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast. BMC Biol 9(1):70
Matecic M, et al.  (2010) A microarray-based genetic screen for yeast chronological aging factors. PLoS Genet 6(4):e1000921
Kowalski D, et al.  (2008) Dysregulation of Purine Nucleotide Biosynthesis Pathways Modulates Cisplatin Cytotoxicity in Saccharomyces cerevisiae. Mol Pharmacol 74(4):1092-100
Paluszynski JP, et al.  (2008) Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast. Microbiology 154(Pt 10):3154-64
Paluszynski JP, et al.  (2006) Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae. Yeast 23(9):707-15
Huang RY, et al.  (2005) Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae. Cancer Res 65(13):5890-7
Yao SY, et al.  (2002) Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem 277(28):24938-48
Escobar-Henriques M and Daignan-Fornier B  (2001) Transcriptional regulation of the yeast gmp synthesis pathway by its end products. J Biol Chem 276(2):1523-30
Wagner R, et al.  (2001) New plasmid system to select for Saccharomyces cerevisiae purine-cytosine permease affinity mutants. J Bacteriol 183(14):4386-8
Ferreira T, et al.  (1999) Evidence for a dynamic role for proline376 in the purine-cytosine permease of Saccharomyces cerevisiae. Eur J Biochem 263(1):57-64
Ferreira T, et al.  (1999) Screening of an intragenic second-site suppressor of purine-cytosine permease from Saccharomyces cerevisiae. Possible role of Ser272 in the base translocation process. Eur J Biochem 260(1):22-30
Kurtz JE, et al.  (1999) New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: requirement of six genes for cytidine metabolism. Curr Genet 36(3):130-6
Ferreira T, et al.  (1998) Role of the proline residue 376 in the catalytic activity of purine-cytosine permease ofSaccharomyces cerevisiae. Folia Microbiol (Praha) 43(2):191-3
Ferreira T, et al.  (1997) Functional analysis of mutated purine-cytosine permease from Saccharomyces cerevisiae. A possible role of the hydrophilic segment 371-377 in the active carrier conformation. J Biol Chem 272(15):9697-702
Guetsova ML, et al.  (1997) The isolation and characterization of Saccharomyces cerevisiae mutants that constitutively express purine biosynthetic genes. Genetics 147(2):383-97
Eddy AA and Hopkins P  (1996) Cytosine accumulation as a measure of the proton electrochemical gradient acting on the overexpressed cytosine permease of Saccharomyces cerevisiae. Microbiology 142 ( Pt 3):449-57
Bloch JC, et al.  (1992) Determination of a specific region of the purine-cytosine permease involved in the recognition of its substrates. Mol Microbiol 6(20):2989-97
Brethes D, et al.  (1992) In vivo and in vitro studies of the purine-cytosine permease of Saccharomyces cerevisiae. Functional analysis of a mutant with an altered apparent transport constant of uptake. Eur J Biochem 204(2):699-704